LumiraDx Limited LumiraDx (NASDAQ: LMDX) Announces its Hba1c Test Achieve CE Marking LumiraDx Limited (NASDAQ: LMDX) confirmed that its Hba1c has earned CE marking. HbA1c is a critical addition to its platform, not just for its current pharmacy and primary care customers,